Navigation Links
EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties
Date:2/18/2008

Out-Licensing Enhances EUSA's Strategic Focus on Late-Stage and Marketed

Products

DOYLESTOWN, Pennsylvania and OXFORD, England, February 18 /PRNewswire/ -- EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has out-licensed the exclusive world-wide rights to its preclinical-stage human anti-interleukin-6 antibody to GlaxoSmithKline (GSK) for a consideration of up to $44 million, comprising an upfront fee and development milestones, plus royalties on future sales. As part of the agreement EUSA will pay approximately 50% of the overall consideration to its development partner for the antibody, Vaccinex Inc. GSK will fund and conduct all future development, production and commercialization of the product.

Interleukin-6 is a pro-inflammatory cytokine and B-cell growth factor and acts as a resistance factor to standard chemotherapy. EUSA's product, OP-R003, is the first fully human anti-interleukin-6 antibody, with target indications in oncology and inflammatory diseases. OP-R003 is derived from a first generation murine antibody, elsilimomab, which has achieved promising clinical results as a lymphoma therapy. As a fully human antibody, OP-R003 has the potential to offer improved tolerability and a superior safety profile.

EUSA acquired OP-R003 as part of the company's 2007 acquisition of OPi SA. OPi had previously entered a collaboration with Vaccinex, a specialist antibody discovery and development company, to optimize and develop OP-R003 as a therapy for rheumatoid arthritis and lymphoma.

"The out-licensing of this early-stage antibody is another strategic milestone for EUSA, as we continue to focus our business on marketed and late-stage products in the oncology, pain control and critical care areas," said Bryan Morton, Chief Executive of EUSA Pharma.

Commenting on the acquisition, Brian McVe
'/>"/>

SOURCE EUSA Pharma Inc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... New Haven Dental Group merges their pr...anford, CT. , (PRWEB) Nov...rised of partners Dr. David Gibson, Dr. Dean Clout...as just merged their growing practice with that of...n Dr. Pickman decided he wanted to retire from den...
(Date:11/20/2009)..., WASHINGTON, Nov. 20 T...ged the Senate to make essential changes its healt...w on abortion funding and conscience protection on...rants and include strong provisions for adequate a...health care bill an "enormous disappointment" that...
(Date:11/20/2009)...ST. LOUIS, Nov. 20 Cen...at it will present at the Bank of America Merrill ...2-3, 2009, at the Crowne Plaza Hotel Times Square ...sday, December 2nd at 8:30 a.m. Eastern Time. Inve...ve, audio webcast of Centene,s presentation at: h...
(Date:11/20/2009)... published online November 20 in the Journal of t...rated fears and hopes that often appear in news co...guidance for both the media and journals to help a...M.S., and Steven Woloshin, M.D., M.S., of Center f...te for Health Policy and Clinical Practice in New ...
(Date:11/20/2009)...it,s as short as 34 weeks, potentially adding to p...IDAY, Nov. 20 (HealthDay News) -- Recent reports s...to climb in the United States. Now, a new study s...out what constitutes a full-term birth in the firs...veyed in the study considered a baby born at 34 to...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4
... can lose their sex drive for up to a year after t... Loss of libido, muted or non-existent orgasm...side effects of the pill. A previous research had,...d by Dr Claudia Panzer, an endocrinologist in Denv...
...ger Toni Braxton wants a baby girl, but is afraid ...oni Braxton as she has pericarditis//. Since ...ewis in 2003, Braxton has been diagnosed with peri...of two said she always wanted two have a big famil...
...s an inspiration today for all of his villagers an... other physically challenged people both in spirit...he age of five years old. Many of his neighbours s...arns handsomely for his entire family. He be...
...r, Mary T. Zhanowicz, reports that police officers...ort and treatment to people with mental illness//.... provide care and help to mentally ill persons and...ead to arrests and deadly encounters. The treatmen...
...molecular biology and genetics in the Johns Hopkin...agues have found that the length of telomeres is i... divide indefinitely. Telomeres are the ends o...gned to protect chromosomes. Every time a cell und...
...f Medicine have found out that an inclination to u...are based more on ethnic background rather than ac...ericans tend to opt for home remedies when compare...ssistant professor of family and community medicin...
Other Medicine News:Health News:‘Never Say Die’ Spirit of Visually Challenged - Makes Him a Role Mod 2Health News:Telomerase Vital In Maintaining Ability of Stem Cell to Multiply 2Health News:Home Remedies More Used By Blacks And Native Americans 2
(Date:11/20/2009)..., NEW YORK, Nov. 20 Medc...ntributing to a transformation in American healthc...hat is already delivering higher quality clinical ...ward -- making medicine smarter for the benefit of...y explained how the elements in its strategy enabl...
(Date:11/20/2009)... , NEW YORK, Nov. 20 Reportlink... is available in its catalogue. ,, Pipettes &a... http://www.reportlinker.com/p0164373/Pipettes--...ource=prnewswire&utm_medium=pr&utm_campaig...eated as an integral part of any research laborato...
(Date:11/20/2009)... , NEW YORK, Nov. 20 Reportlink... is available in its catalogue. ,, Medical Adh...http://www.reportlinker.com/p0164242/Medical-Adhes...urce=prnewswire&utm_medium=pr&utm_campaign...nd sealants is gaining preeminence in medical devi...
Breaking Medicine Technology:Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Researchers find that eating high levels of fructose impairs memory in rats 51974 1Researchers find that eating high levels of fructose impairs memory in rats 51974 2NHP Announces Second Quarter Earnings Release Date and Webcast Conference Call 51969 1NHP Announces Second Quarter Earnings Release Date and Webcast Conference Call 51969 2Congressmen Mike Ross and Kendrick Meek Introduce Bill to Protect Medicare Patients Who Require Medical Oxygen Therapy at Home 51965 1Congressmen Mike Ross and Kendrick Meek Introduce Bill to Protect Medicare Patients Who Require Medical Oxygen Therapy at Home 51965 2Congressmen Mike Ross and Kendrick Meek Introduce Bill to Protect Medicare Patients Who Require Medical Oxygen Therapy at Home 51965 3
...alif., Jan. 8 Nektar,Therapeutics (Nasdaq: NKTR ...l development program to evaluate NKTR-102 (PEG-ir...cancer. NKTR-102 is Nektar,s lead,oncolytic candid...PEGylation technology platform., "The start of th...r is,a major achievement for Nektar," said Howard ...
...8 Surface Logix today announced positive,results ...01 in,hypertension. The randomized, double-blind, ...patients with uncontrolled hypertension demonstrat...uctions in blood pressure,and was well tolerated. ...ability and effect on blood pressure in patients o...
Other Medicine Technology:Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer 2Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer 3Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer 4Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension 2Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension 3
...ble to determine the,vitamin levels in an easy, fa...nts in,ready to use form for preparation and separ.... ,The advantage of HPLC analytics is the simultan...he HPLC complete,system enables even laboratories ...
Steroid 21-Hydroxylase (21-OH) Autoantibody RIA
...tended for the quantitative determination of thyro...ensitive ELISA procedure offers sensitivity of 0.0...curate establishment of post-ablation serum Tg lev...urthermore, with the ability to accurately detect ...
...12 channel pipettors. Angled sides and V-shaped bo...ion. Corners have pouring lips to dispose of exces...taining no regrinds. Sterile 5/bag packaging for h...sions: 78 mm W x 152 mm L x 35 mm H (2 13/16 x 6 x...
Medicine Products: